Fifth Third Bancorp Amicus Therapeutics, Inc. Transaction History

Fifth Third Bancorp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$9.82 - $12.44 $2,091 - $2,649	-213 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$8.71 - $10.72 $4,990 - $6,142	-573 Reduced 72.9%	213 $2,000
Q1 2021 May 07, 2021	SELL	$9.2 - $23.86 $1,803 - $4,676	-196 Reduced 19.96%	786 $8,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $113,403 - $209,548	-8,419 Reduced 89.55%	982 $23,000
Q3 2020 Nov 09, 2020	BUY	$12.89 - $15.89 $121,178 - $149,381	9,401 New	9,401 $133,000
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $2,161 - $3,106	-289 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $2,317 - $3,829	289 New	289 $2,000
Q1 2019 May 14, 2019	SELL	$10.04 - $13.92 $9,688 - $13,432	-965 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $8,086 - $12,969	965 New	965 $9,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.84B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.